News | January 01, 2025
Anthem Biosciences files DRHP for Rs. 3,395 crore IPO
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Anthem’s business comprises of CRDMO services and the manufacture and sale of Specialty Ingredients
Infections with H. pylori affect over 43 percent of the world’s population with a wide range of gastrointestinal disorders
The transaction is expected to result in approximately $175 million to support further development of IMG-007
The TPE Tourniquet and TPE Esmark Bandages are renowned for their single-use design,
The segment has immense growth potential driven by the country's increasing healthcare needs, technological innovations, government support, and emerging market opportunities
This facility marks a significant milestone in transforming the global food industr
The facility houses 33 reactors, comprising stainless steel and glass-lined varieties, with capacities ranging from 1.6 KL to 16 KL
Demonstrates vision gains with extended treatment intervals in retinal vein occlusion
Harnessing advanced data analysis for early detection, prevention and better outcomes
First and only PARP inhibitor to improve overall survival in early breast cancer
Subscribe To Our Newsletter & Stay Updated
